--- title: "Jinxin Fertility Cancels 52.7 Million Repurchased Shares to Lift Per-Share Metrics" type: "News" locale: "en" url: "https://longbridge.com/en/news/282193139.md" description: "Jinxin Fertility Group Ltd. has cancelled 52.7 million repurchased shares, reducing its total issued share capital to 2.7 billion shares. This move aims to enhance net asset value and earnings per share, reflecting the company's commitment to shareholder value. The company plans to continue this strategy for future buybacks. Currently, the stock holds a Hold rating with a price target of HK$2.50. Jinxin operates in the fertility and assisted reproductive services sector, focusing on the growing reproductive healthcare market in Asia." datetime: "2026-04-09T11:43:04.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/282193139.md) - [en](https://longbridge.com/en/news/282193139.md) - [zh-HK](https://longbridge.com/zh-HK/news/282193139.md) --- # Jinxin Fertility Cancels 52.7 Million Repurchased Shares to Lift Per-Share Metrics ### Easter Sale - 70% Off TipRanks - Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions - Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks Jinxin Fertility Group Ltd. ( (HK:1951) ) has shared an update. Jinxin Fertility Group Limited has cancelled 52,662,000 shares that it previously repurchased under general mandates granted in 2024 and 2025, reducing its total issued share capital from 2,757,706,043 to 2,705,044,043 shares. The board expects the cancellation of these repurchased shares to enhance net asset value and earnings per share and plans to continue using a similar cancel-and-retire approach for buybacks during 2026, signaling an ongoing focus on shareholder value. The move underscores the company’s capital management strategy at a time when fertility and reproductive healthcare providers are competing to differentiate themselves in the market. By shrinking the share base, Jinxin Fertility aims to strengthen its financial metrics and potentially improve its appeal to investors, while retaining flexibility to repeat such cancellations as future repurchases are executed. The most recent analyst rating on (HK:1951) stock is a Hold with a HK$2.50 price target. To see the full list of analyst forecasts on Jinxin Fertility Group Ltd. stock, see the HK:1951 Stock Forecast page. **More about Jinxin Fertility Group Ltd.** Jinxin Fertility Group Limited is a Cayman Islands-incorporated company listed in Hong Kong that operates in the fertility and assisted reproductive services sector. The group focuses on providing medical treatments and related services for fertility patients, positioning itself within the growing reproductive healthcare market in China and broader Asia. **Average Trading Volume:** 22,615,482 **Technical Sentiment Signal:** Hold **Current Market Cap:** HK$6.86B ### Related Stocks - [LABU.US](https://longbridge.com/en/quote/LABU.US.md) - [IVF.US](https://longbridge.com/en/quote/IVF.US.md) - [159849.CN](https://longbridge.com/en/quote/159849.CN.md) - [516610.CN](https://longbridge.com/en/quote/516610.CN.md) - [IHI.US](https://longbridge.com/en/quote/IHI.US.md) - [159898.CN](https://longbridge.com/en/quote/159898.CN.md) - [159837.CN](https://longbridge.com/en/quote/159837.CN.md) - [XHE.US](https://longbridge.com/en/quote/XHE.US.md) - [IBB.US](https://longbridge.com/en/quote/IBB.US.md) - [BBH.US](https://longbridge.com/en/quote/BBH.US.md) - [BIB.US](https://longbridge.com/en/quote/BIB.US.md) - [XBI.US](https://longbridge.com/en/quote/XBI.US.md) - [IHF.US](https://longbridge.com/en/quote/IHF.US.md) - [562600.CN](https://longbridge.com/en/quote/562600.CN.md) - [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md) - [516500.CN](https://longbridge.com/en/quote/516500.CN.md) - [FBT.US](https://longbridge.com/en/quote/FBT.US.md) - [XHS.US](https://longbridge.com/en/quote/XHS.US.md) - [516930.CN](https://longbridge.com/en/quote/516930.CN.md) - [XLV.US](https://longbridge.com/en/quote/XLV.US.md) - [01951.HK](https://longbridge.com/en/quote/01951.HK.md) - [PBE.US](https://longbridge.com/en/quote/PBE.US.md) - [159883.CN](https://longbridge.com/en/quote/159883.CN.md) - [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md) - [VHT.US](https://longbridge.com/en/quote/VHT.US.md) ## Related News & Research - [Radnor Capital Management LLC Has $1.65 Million Stock Holdings in West Pharmaceutical Services, Inc. $WST](https://longbridge.com/en/news/286893528.md) - [Resona Asset Management Co. Ltd. Cuts Position in Danaher Corporation $DHR](https://longbridge.com/en/news/286897088.md) - [Dogwood Therapeutics Announces Commencement of Halneuron® Chemotherapy Induced Neuropathic Pain Phase 2b Long Term Extension Study | DWTX Stock News](https://longbridge.com/en/news/286772955.md) - [Northwestern Mutual Wealth Management Co. Purchases 100,968 Shares of Medpace Holdings, Inc. $MEDP](https://longbridge.com/en/news/286744952.md) - [BUZZ-Dexcom to add two directors in deal with activist Elliott; shares up](https://longbridge.com/en/news/286465778.md)